Cme Group annual capital expenditures (capex)
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Cme Group Capital Expenditures (CapEx) Growth & History (CME)
Cme Group's capital expenditures (capex) was $83.5M for fiscal 2025.
View full Cme Group company overviewCme Group annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $83.5M | −$10.5M | −11.17% |
| 2024 | 2024-12-31 | $94.0M | $17.6M | +23.04% |
| 2023 | 2023-12-31 | $76.4M | −$13.3M | −14.83% |
| 2022 | 2022-12-31 | $89.7M | −$37.5M | −29.48% |
| 2021 | 2021-12-31 | $127.2M | −$70.3M | −35.59% |
| 2020 | 2020-12-31 | $197.5M | −$48.1M | −19.58% |
| 2019 | 2019-12-31 | $245.6M | $128.9M | +110.45% |
| 2018 | 2018-12-31 | $116.7M | $34.8M | +42.49% |
| 2017 | 2017-12-31 | $81.9M | −$9.9M | −10.78% |
| 2016 | 2016-12-31 | $91.8M | −$22.4M | −19.61% |
| 2015 | 2015-12-31 | $114.2M | −$26.5M | −18.83% |
| 2014 | 2014-12-31 | $140.7M | $15.1M | +12.02% |
| 2013 | 2013-12-31 | $125.6M | −$16.2M | −11.42% |
| 2012 | 2012-12-31 | $141.8M | −$30.4M | −17.65% |
| 2011 | 2011-12-31 | $172.2M | $12.2M | +7.63% |
| 2010 | 2010-12-31 | $160.0M | $2.1M | +1.33% |
| 2009 | 2009-12-31 | $157.9M | −$42.2M | −21.09% |
| 2008 | 2008-12-31 | $200.1M | $36.4M | +22.24% |
| 2007 | 2007-12-31 | $163.7M | — | — |
Cme Group quarterly capital expenditures (capex)
Q3.08
Q1.09
Q2.09
Q3.09
Q4.09
Q1.10
Q2.10
Q3.10
Q4.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $23.6M | $5.2M | +28.26% |
| Q1 2026 | 2026-03-31 | $21.8M | $7.6M | +53.52% |
| Q4 2025 | 2025-12-31 | $32.5M | $6.3M | +24.05% |
| Q3 2025 | 2025-09-30 | $18.4M | −$11.4M | −38.26% |
| Q2 2025 | 2025-06-30 | $18.4M | $200,000 | +1.10% |
| Q1 2025 | 2025-03-31 | $14.2M | −$5.6M | −28.28% |
| Q4 2024 | 2024-12-31 | $26.2M | $5.4M | +25.96% |
| Q3 2024 | 2024-09-30 | $29.8M | $9.9M | +49.75% |
| Q2 2024 | 2024-06-30 | $18.2M | −$2.3M | −11.22% |
| Q1 2024 | 2024-03-31 | $19.8M | $4.6M | +30.26% |
| Q4 2023 | 2023-12-31 | $20.8M | −$3.6M | −14.75% |
| Q3 2023 | 2023-09-30 | $19.9M | −$4.1M | −17.08% |
| Q2 2023 | 2023-06-30 | $20.5M | $2.6M | +14.53% |
| Q1 2023 | 2023-03-31 | $15.2M | −$8.2M | −35.04% |
| Q4 2022 | 2022-12-31 | $24.4M | −$2.9M | −10.62% |
| Q3 2022 | 2022-09-30 | $24.0M | −$7.7M | −24.29% |
| Q2 2022 | 2022-06-30 | $17.9M | −$21.8M | −54.91% |
| Q1 2022 | 2022-03-31 | $23.4M | −$5.1M | −17.89% |
| Q4 2021 | 2021-12-31 | $27.3M | −$42.7M | −61.00% |
| Q3 2021 | 2021-09-30 | $31.7M | −$16.6M | −34.37% |
| Q2 2021 | 2021-06-30 | $39.7M | $3.3M | +9.07% |
| Q1 2021 | 2021-03-31 | $28.5M | −$14.3M | −33.41% |
| Q4 2020 | 2020-12-31 | $70.0M | $3.6M | +5.42% |
| Q3 2020 | 2020-09-30 | $48.3M | −$9.3M | −16.15% |
| Q2 2020 | 2020-06-30 | $36.4M | −$36.1M | −49.79% |
| Q1 2020 | 2020-03-31 | $42.8M | −$6.3M | −12.83% |
| Q4 2019 | 2019-12-31 | $66.4M | $10.6M | +19.00% |
| Q3 2019 | 2019-09-30 | $57.6M | $26.3M | +84.03% |
| Q2 2019 | 2019-06-30 | $72.5M | $61.1M | +535.96% |
| Q1 2019 | 2019-03-31 | $49.1M | $30.9M | +169.78% |
| Q4 2018 | 2018-12-31 | $55.8M | $26.9M | +93.08% |
| Q3 2018 | 2018-09-30 | $31.3M | $15.9M | +103.25% |
| Q2 2018 | 2018-06-30 | $11.4M | −$6.2M | −35.23% |
| Q1 2018 | 2018-03-31 | $18.2M | −$1.8M | −9.00% |
| Q4 2017 | 2017-12-31 | $28.9M | $0 | 0.00% |
| Q3 2017 | 2017-09-30 | $15.4M | −$7.9M | −33.91% |
| Q2 2017 | 2017-06-30 | $17.6M | −$1.8M | −9.28% |
| Q1 2017 | 2017-03-31 | $20.0M | −$200,000 | −0.99% |
| Q4 2016 | 2016-12-31 | $28.9M | $5.0M | +20.92% |
| Q3 2016 | 2016-09-30 | $23.3M | −$6.3M | −21.28% |
| Q2 2016 | 2016-06-30 | $19.4M | −$9.9M | −33.79% |
| Q1 2016 | 2016-03-31 | $20.2M | −$11.2M | −35.67% |
| Q4 2015 | 2015-12-31 | $23.9M | −$12.6M | −34.52% |
| Q3 2015 | 2015-09-30 | $29.6M | $2.8M | +10.45% |
| Q2 2015 | 2015-06-30 | $29.3M | −$11.6M | −28.36% |
| Q1 2015 | 2015-03-31 | $31.4M | −$5.1M | −13.97% |
| Q4 2014 | 2014-12-31 | $36.5M | $5.6M | +18.12% |
| Q3 2014 | 2014-09-30 | $26.8M | −$12.1M | −31.11% |
| Q2 2014 | 2014-06-30 | $40.9M | $5.3M | +14.89% |
| Q1 2014 | 2014-03-31 | $36.5M | $16.3M | +80.69% |
| Q4 2013 | 2013-12-31 | $30.9M | −$7.0M | −18.47% |
| Q3 2013 | 2013-09-30 | $38.9M | −$1.4M | −3.47% |
| Q2 2013 | 2013-06-30 | $35.6M | −$1.3M | −3.52% |
| Q1 2013 | 2013-03-31 | $20.2M | −$6.5M | −24.34% |
| Q4 2012 | 2012-12-31 | $37.9M | −$4.9M | −11.45% |
| Q3 2012 | 2012-09-30 | $40.3M | −$700,000 | −1.71% |
| Q2 2012 | 2012-06-30 | $36.9M | −$10.1M | −21.49% |
| Q1 2012 | 2012-03-31 | $26.7M | −$14.7M | −35.51% |
| Q4 2011 | 2011-12-31 | $42.8M | −$19.5M | −31.30% |
| Q3 2011 | 2011-09-30 | $41.0M | −$2.9M | −6.61% |
| Q2 2011 | 2011-06-30 | $47.0M | $19.5M | +70.91% |
| Q1 2011 | 2011-03-31 | $41.4M | $15.1M | +57.41% |
| Q4 2010 | 2010-12-31 | $62.3M | $17.3M | +38.44% |
| Q3 2010 | 2010-09-30 | $43.9M | $10.0M | +29.50% |
| Q2 2010 | 2010-06-30 | $27.5M | −$16.2M | −37.07% |
| Q1 2010 | 2010-03-31 | $26.3M | −$9.0M | −25.50% |
| Q4 2009 | 2009-12-31 | $45.0M | — | — |
| Q3 2009 | 2009-09-30 | $33.9M | −$8.2M | −19.48% |
| Q2 2009 | 2009-06-30 | $43.7M | — | — |
| Q1 2009 | 2009-03-31 | $35.3M | — | — |
| Q3 2008 | 2008-09-30 | $42.1M | — | — |
Cme Group capital expenditures (capex) trends
Over the last five fiscal years, Cme Group's capital expenditures (capex) decreased from $197.5M to $83.5M, a change of −$114.0M. The latest reported quarter, Q2 2026, shows $23.6M.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cme Group source filings ↗Community posts
CME plans European dairy futures and options through EEX transition
CME Group ($CME) agreed with the European Energy Exchange to transition EEX’s European dairy business, including its butter and skimmed-milk-powder indices, as EEX phases out those products. CME plans to establish its own European dairy ind ...
CME sets an FX open-interest record of 4.41 million contracts
CME Group reported a new foreign-exchange derivatives milestone on 7 September 2026. Reported records FX futures and options open interest reached 4,410,167 contracts on 4 September, exceeding the previous 4,269,622 record from 11 June. Tha ...